Shanghai-based pharmaceutical giant WuXi AppTec reported a 38.9% revenue surge to RMB 28.90 billion for the first half of 2026, prompting the company to raise its full-year financial guidance as its integrated CRDMO platform continues to benefit from the commercial success of its customers' drug products.
Hyperscale Data has secured approximately $30 million in financing through the Morpho Protocol, leveraging its Bitcoin treasury as collateral to fund the expansion of its Michigan AI data center. The move marks a strategic shift toward using decentralized finance to access capital while retaining long-term digital asset exposure.
AusperBio Therapeutics has dosed the first patient in a clinical study for AHB-171, an investigational siRNA therapeutic designed to treat chronic hepatitis B. This milestone marks the first clinical application of the company's proprietary Au-HALO liver-targeting platform, expanding its pipeline beyond its existing lead program, AHB-137.
The United States currently imports nearly all of its merchant pig iron, a strategic vulnerability that MagIron aims to close by establishing large-scale domestic production. A new economic study from Primetals Technologies confirms that MagIron’s existing infrastructure could support an output of two million tonnes per year.
The 2026 World Dairy Industry Conference opened in Hohhot, Inner Mongolia, on August 1, as the International Union of Food Science and Technology formally designated the city the World Dairy Capital. Hosted by Yili Group, the gathering focuses on accelerating technological integration and cross-border partnerships across the global dairy value chain.
Hundreds of young innovators gathered at the Pan Am Centre in Markham, Ontario, from July 18 to 20 for the inaugural ENJOY AI 2026 Americas Open. The event drew students from Canada, Mexico, Türkiye, and Ethiopia, marking a significant expansion for the international robotics and STEM competition network.
Investors who purchased Regeneron Pharmaceuticals stock between August 1, 2025, and May 15, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding the clinical success of its Phase III Fianlimab-Libtayo study by utilizing flawed statistical assumptions.
With 1,006 patients enrolled across seven medical centers, Invenio Imaging has finalized the ON-SITE study, a pivotal clinical trial testing an AI-based module designed to provide real-time assessment of lung biopsy specimens during bronchoscopic procedures, potentially solving long-standing diagnostic bottlenecks in the operating room.
For years, companies hiring internationally have faced unpredictable costs hidden behind opaque surcharges and FX markups. Multiplier, the Global Exchange for Work, is challenging this industry standard by publishing its complete Employer of Record pricing structure directly on its website, promising total cost predictability for finance and HR teams.
Scaling from 80 to 200 inches, the new Hisense PX4 Pro TriChroma Laser Cinema aims to bridge the gap between professional theater performance and living room utility. The device leverages a 3,500 ANSI lumen output to maintain image clarity during daylight hours while targeting both cinephiles and competitive gamers.
Banyan Group has expanded its flagship hospitality footprint in China with the launch of Banyan Tree Mount Emei. Located in the foothills of Sichuan’s revered sacred mountain, the 130-room resort integrates contemporary architecture with the natural topography of a forested valley, offering direct access to the UNESCO World Heritage site.
Transforming the living room into a theater, Hisense has launched the PX4 Pro, a TriChroma laser projector capable of casting images up to 200 inches. The device aims to bridge the gap between high-end professional cinema and everyday household utility, balancing daylight brightness with advanced gaming performance features.
HUMAIN has secured its first investment in a Saudi company by backing MOZN, an enterprise AI firm specializing in high-assurance sectors. The partnership aims to integrate HUMAIN’s full-stack infrastructure with MOZN’s engineering model to accelerate production-scale AI deployments for global financial institutions and government organizations.
A class action lawsuit filed in Los Angeles alleges that Wix.com misled shareholders regarding the competitive viability and development costs of its artificial intelligence tools. The litigation, which covers the period from February 2025 through May 2026, claims the company provided false information to the market throughout the class period.
Shareholders who held GPGI, Inc. stock between November 3, 2025, and May 6, 2026, face a September 15, 2026, deadline to join a class action lawsuit. The litigation centers on claims that the company misled investors regarding the financial health and valuation of its Husky Technologies Limited division.
Investors who held Insulet Corporation stock between February 21, 2025, and May 26, 2026, face an August 31 deadline to join a class action lawsuit. The litigation alleges the company misled the market regarding the integrity of its manufacturing processes and the safety of its medical devices.
Investors who held Insulet Corporation stock between February 21, 2025, and May 26, 2026, face an August 31, 2026, deadline to join a securities fraud class action. The lawsuit, filed by Schall Brown & Schwartz LLP, alleges the medical device manufacturer misled the market regarding its internal manufacturing controls and product safety.
Investors who purchased Planet Fitness, Inc. securities between November 6, 2025, and May 6, 2026, face a September 14, 2026, deadline to seek lead plaintiff status. Schall Brown & Schwartz LLP is currently organizing a class action lawsuit against the company for alleged violations of the Securities Exchange Act.
A New York-based investor rights firm is escalating its investigation into The Ensign Group, alleging the nursing home operator provided shareholders with materially misleading business information. The probe follows a sharp decline in share value prompted by claims of systemic understaffing and manipulated quality metrics at the company’s facilities.
Investors who purchased Regeneron Pharmaceuticals stock between August 1, 2025, and May 15, 2026, are facing a legal deadline of September 14, 2026, to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act following the disclosure of disappointing clinical trial results.
Investors who purchased ZoomInfo Technologies Inc. shares between November 3, 2025, and May 11, 2026, are facing a critical window to join a securities fraud lawsuit. Schall, Brown & Schwartz LLP is currently seeking lead plaintiffs after allegations emerged that the software firm misled the market regarding its actual growth trajectory.
Investors who purchased ZoomInfo Technologies stock between November 3, 2025, and May 11, 2026, face a critical deadline to join a class action lawsuit. The DJS Law Group alleges the company misled the market regarding the viability of its AI-powered products while customers shifted toward in-house alternatives.
Dynamic search filters and personalized dashboards headline the latest release of BOC Group’s ADOIT 20.0, an enterprise architecture suite designed to streamline data accessibility. By shifting from static repositories to interactive workspaces, the platform aims to help organizations manage complex transformations through automated compliance assessments and improved review protocols.
Tajikistan’s national carrier has taken delivery of its first Boeing 737-8, marking a significant milestone in the airline’s fleet modernization strategy. The aircraft, leased from Dubai Aerospace Enterprise, stands as the first 737 MAX to operate within the Central Asian nation, providing a platform for expanded international service.
More than 1,200 unit trains have moved across the U.S. via Rail Modal Group, a logistics platform now under the majority control of InfraRed Capital Partners. The acquisition aims to scale RMG's inland terminal operations, which bridge the gap between agricultural producers in the Midwest and international shipping ports.
Founded in 1976 as Chisholm Plastics, the Liverpool manufacturer Centriforce Products Ltd is marking its 50th anniversary by scaling its output of recycled plastic infrastructure protection. What began as a niche venture focused on post-consumer waste has evolved into a global operation exporting to more than 50 countries.
A decade into its operation, the U.S. inland intermodal rail terminal provider Rail Modal Group is entering a new phase of expansion after being acquired by InfraRed Capital Partners. The deal, which maintains founder Greg Oberting in his leadership role, aims to scale the platform’s capacity within the agricultural supply chain.
Fifty years ago, Liverpool-based manufacturer Centriforce began transforming industrial waste into functional protection products, long before sustainability became a corporate mandate. As the firm celebrates its 2026 milestone, its original business model has shifted from a niche recycling effort to the essential regulatory baseline for global infrastructure projects.
Investors who purchased Primoris Services Corporation stock between August 5, 2025, and June 22, 2026, are facing a legal deadline of September 21, 2026, to join a class action lawsuit. The litigation alleges the firm misled shareholders regarding cost estimations and risk management for its renewable energy portfolio.
A class action lawsuit has been filed against EquipmentShare.com Inc., accusing the company of violating the Securities Exchange Act. The litigation centers on claims that the firm misled shareholders by failing to disclose specific related-party transactions throughout the first half of 2026, causing potential losses for market participants.
